Who Owns Addex Therapeutics Stock?
NASDAQ: ADXNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:33 AM ET
Ownership breakdown
- Held by institutions
- 0.01%
- Held by insiders
- 0.00%
- Institutional holders
- 2
- Institutions 0.0%
- Insiders 0.0%
- Public and other 100.0%
Who owns Addex Therapeutics stock?
Institutional investors own about 0.0% of Addex Therapeutics's shares, spread across 2 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of ADXN.
The largest institutional holders are UBS Group AG (0.00%) and SBI Securities Co., Ltd. (0.00%).
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ADXN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| UBS Group AG | 47 | 0.00% | +100.0% |
| SBI Securities Co., Ltd. | 1 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Frequently asked questions
Who is the largest shareholder of Addex Therapeutics?
UBS Group AG is the largest institutional shareholder of ADXN, owning 0.00% of shares outstanding (47 shares) as of its latest 13F filing.
What percentage of Addex Therapeutics is owned by institutions?
Institutions own about 0.0% of ADXN shares and 0.0% of the public float.
How much of Addex Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.00% of ADXN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.